ClinicalTrials.Veeva

Menu

Accurate Classification System for Patients With COVID-19 Pneumonitis

W

Wuhan University

Status

Completed

Conditions

Pneumonitis

Study type

Observational

Funder types

Other

Identifiers

NCT04302688
COVID-19 WU1

Details and patient eligibility

About

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Full description

  1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
  2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
  3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Enrollment

669 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion criteria

  • Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
  • Suspected patient review refers to the negative nucleic acid test.

Trial design

669 participants in 2 patient groups

modeling cohort
Description:
The 445 patients were grouped in chronological order.
validating colort
Description:
The remaining 224 patients.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems